Radiopharmaceutical contract development manufacturer Evergreen Theragnostics Inc. opened its new facility in Springfield, the company announced Oct. 18.
With the new location, Evergreen can serve the manufacturing needs of companies developing and commercializing radiopharmaceuticals from preclinical and early-stage clinical trials to full scale commercial manufacturing of approved products.
The 14,000-square-foot facility meets global current Good Manufacturing Practice standards for radiopharmaceutical manufacturing, including therapeutic and centrally distributed diagnostic products.
The facility, which employs a fully electronic Quality Management System and Laboratory Information Management System and is licensed to safely handle a wide variety of radionuclides, has seven commercial scale production suites. Two of the suites are available for future customization based on customer needs, along with a research space, multiple sterility lines, quality control, material storage, and packaging space.
“We set out to build a world-class facility, and we think we’ve achieved that. The facility provides high capacity, flexibility, efficient workflows, and even great aesthetics,” said Chief Executive Officer James Cook in a prepared statement. “We are pleased to have opened just two years after initiating the project, and we can’t wait to begin manufacturing for our customers and delivering for patients.”
With proximity to Newark Liberty International Airport in New Jersey and John F. Kennedy International Airport in New York, Evergreen said its facility can manage both incoming raw material supply chains from Europe and the U.S., and outgoing delivery to North American customers “on a just-in-time basis.”